Developmental origins of health and disease: Environmental exposures

Seminars in Reproductive Medicine

Volumn 27, Issue 5, 2009, Pages 391-402

  Swanson, James M ^a   Entringer, Sonja ^a   Buss, Claudia ^a   Wadhwa, Pathik D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antidepressants; DOHaD; Environment; Epigenetic; Folic acid; Smoking

Indexed keywords

ANTICONVULSIVE AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHROMONE DERIVATIVE; CITALOPRAM; CORTICOSTEROID; FLUOXETINE; FOLIC ACID; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TOBACCO SMOKE; VENLAFAXINE;

ANXIETY DISORDER; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; DIETARY INTAKE; DRUG WITHDRAWAL; ENVIRONMENTAL EXPOSURE; EPIGENETICS; FETUS DEVELOPMENT; FETUS MALFORMATION; FOLIC ACID DEFICIENCY; GENE INTERACTION; GENOTYPE; GROWTH RETARDATION; HUMAN; HYPOPLASIA; MATERNAL HYPERTENSION; MATERNAL NUTRITION; MUSCLE HYPOTONIA; NERVOUSNESS; NEWBORN DISEASE; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURE LABOR; PULMONARY HYPERTENSION; REPRODUCTION; RESPIRATORY TRACT DISEASE; REVIEW; SEIZURE; SIDE EFFECT;

ADAPTATION, PHYSIOLOGICAL; ADULT; ANTIDEPRESSIVE AGENTS; ENVIRONMENT; EPIGENESIS, GENETIC; FEMALE; FETAL DEVELOPMENT; FOLIC ACID DEFICIENCY; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GENOMIC IMPRINTING; HUMANS; INFANT, NEWBORN; MALE; MODELS, GENETIC; POPULATION SURVEILLANCE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; REPRODUCTION; SMOKING;

EID: 69349093731     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0029-1237427     Document Type: Review

References (87)

1. Wadhwa PD, Buss C, Entringer S, Swanson JD. Developmental origins of health and disease: brief history of the approach and current focus on epigenetic mechanisms. Semin Reprod Med 2009;27(5):358-368
2. Barker DJ, Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1986;1(8489):1077-1081 (Pubitemid 16106274)
3. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in infancy and death from ischaemic heart disease. Lancet 1989;2(8663):577-580 (Pubitemid 19216205)
4. Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS. Fetal nutrition and cardiovascular disease in adult life. Lancet 1993;341(8850):938-941 (Pubitemid 23109122)
5. Bar-Oz B, Einarson T, Einarson A, et al. Paroxetine and congenital malformations: meta-analysis and consideration of potential confounding factors. Clin Ther 2007;29(5):918-926 (Pubitemid 47223423)
6. Hales CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992;35(7):595-601
7. Gluckman P, Hanson M. Developmental Origins of Health and Disease. Cambridge, United Kingdom: Cambridge University Press; 2006
8. Gluckman PD, Hanson MA, Beedle AS. Non-genomic transgenerational inheritance of disease risk. Bioessays 2007; 29(2):145-154
9. Jirtle RL, Skinner MR. Epigenetics: a window on gene dysregulation and disease. Nature Genetics Reviews 2007; 8(4):253-263
10. Waterland RA, Michels KB. Epigenetic epidemiology of the developmental origins hypothesis. Annu Rev Nutr 2007;27: 363-388
11. Bala M, Strzeszynski L, Cahill K. Mass media interventions for smoking cessation in adults. Cochrane Database Syst Rev 2008;(1):CD004704 (Pubitemid 351807612)
12. Messer K, Pierce JP, Zhu SH, et al. The California Tobacco Control Program's effect on adult smokers: (1) Smoking cessation. Tob Control 2007;16(2):85-90
13. Rovniak LS, Johnson-Kozlow MF, Hovell MF. Reducing the gap between the economic costs of tobacco and funds for tobacco training in schools of public health. Public Health Rep 2006;121(5):538-546
14. U.S. Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta, Georgia: U.S. Department of Health and Human Services, CDC, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2004
15. U.S. Department of Health and Human Services. The Health Consequences of Involuntary Exposure to Tobacco Smoke. A Report of the Surgeon General-Executive Summary. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2006
16. Simpson WJ. A preliminary report on cigarette smoking and the incidence of prematurity. Am J Obstet Gynecol 1957; 73(4):807-815
17. Yerushalmy J. The relationship of parents' cigarette smoking to outcome of pregnancy - implications as to the problem of inferring causation from observed associations. Am J Epidemiol 1971;93(6):443-456
18. Olsen J. Cigarette smoking in pregnancy and fetal growth. Does the type of tobacco play a role? Int J Epidemiol 1992; 21(2):279-284
19. Herrmann M, King K, Weitzman M. Prenatal tobacco smoke and postnatal secondhand smoke exposure and child neurodevelopment. Curr Opin Pediatr 2008;20(2): 184-190
20. Stroud LR, Paster RL, Goodwin MS, et al. Maternal smoking during pregnancy and neonatal behavior: a large-scale community study. Pediatrics 2009;123(5):e842-e848
21. Aagaard-Tillery KM, Porter TF, Lane RH, Varner MW, Lacoursiere DY. In utero tobacco exposure is associated with modified effects of maternal factors on fetal growth. Am J Obstet Gynecol 2008;198(1):61-66
22. Lumley J, Oliver SS, Chamberlain C, Oakley L. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2004;(4):CD001055
23. Jaddoe VW, Verburg BO, de Ridder MA, et al. Maternal smoking and fetal growth characteristics in different periods of pregnancy: the generation R study. Am J Epidemiol 2007; 165(10):1207-1215
24. Li CQ, Windsor RA, Perkins L, Goldenberg RL, Lowe JB. The impact on infant birth weight and gestational age of cotinine-validated smoking reduction during pregnancy. JAMA 1993;269(12):1519-1524 (Pubitemid 23086412)
25. McCowan LM, Dekker GA, Chan E, et al; SCOPE consortium. Spontaneous preterm birth and small for gestational age infants in women who stop smoking early in pregnancy: prospective cohort study. BMJ 2009;338:b1081
26. March of Dimes. Preconception health and healthcare. Available at: http://www.marchofdimes.com/professionals/ 19695-1171.asp. Accessed July 2, 2009
27. Toschke AM, Montgomery SM, Pfeiffer U, von Kries R. Early intrauterine exposure to tobacco-inhaled products and obesity. Am J Epidemiol 2003;158(11):1068-1074 (Pubitemid 37475090)
28. von Kries R, Bolte G, Baghi L, Toschke A; MGME Study Group. Parental smoking and childhood obesity - is maternal smoking in pregnancy the critical exposure? Int J Epidemiol 2008;37(1):210-216
29. Oken E, Levitan EB, Gillman MW. Maternal smoking during pregnancy and child overweight: systematic review and meta-analysis. Int J Obes (Lond) 2008;32(2):201-210 (Pubitemid 351271794)
30. Leonardi-Bee J, Smyth A, Britton J, Coleman T. Environmental tobacco smoke and fetal health: systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2008; 93(5):F351-F361
31. Eskenazi B, Castorina R. Association of prenatal maternal or postnatal child environmental tobacco smoke exposure and neurodevelopmental and behavioral problems in children. Environ Health Perspect 1999;107(12):991-1000 (Pubitemid 30040581)
32. Braun JM, Kahn RS, Froehlich T, Auinger P, Lanphear BP. Exposures to environmental toxicants and attention deficit hyperactivity disorder in U.S. children. Environ Health Perspect 2006;114(12):1904-1909 (Pubitemid 44873693)
33. Perera FP, Rauh V, Whyatt RM, et al. A summary of recent findings on birth outcomes and developmental effects of prenatal ETS, PAH, and pesticide exposures. Neurotoxicology 2005;26(4):573-587
34. Wenten M, Li YF, Lin PC, et al. In utero smoke exposure, glutathione S-transferase P1 haplotypes, and respiratory illness-related absence among schoolchildren. Pediatrics 2009;123(5):1344-1351
35. Shi M, Wehby GL, Murray JC. Review on genetic variants and maternal smoking in the etiology of oral clefts and other birth defects. Birth Defects Res C Embryo Today 2008; 84(1):16-29
36. Hirschhorn JN. Genomewide association studies - illuminating biologic pathways. N Engl J Med 2009;360(17):1699-1701
37. ShiM, Christensen K, Weinberg CR, et al. Orofacial cleft risk is increased with maternal smoking and specific detoxification-gene variants. Am J Hum Genet 2007;80(1):76-90 (Pubitemid 46047652)
38. Wang X, Zuckerman B, Pearson C, et al. Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. JAMA 2002;287(2):195-202 (Pubitemid 34251944)
39. Tsai HJ, Liu X, Mestan K, et al. Maternal cigarette smoking, metabolic gene polymorphisms, and preterm delivery: new insights on GxE interactions and pathogenic pathways. Hum Genet 2008;123(4):359-369
40. Yu Y, Tsai HJ, Liu X, et al. The joint association between F5 gene polymorphisms and maternal smoking during pregnancy on preterm delivery. Hum Genet 2009;124(6):659-668
41. Kahn RS, Khoury J, Nichols WC, Lanphear BP. Role of dopamine transporter genotype and maternal prenatal smoking in childhood hyperactive-impulsive, inattentive, and oppositional behaviors. J Pediatr 2003;143(1):104-110 (Pubitemid 36928576)
42. Neuman RJ, Lobos E, Reich W, Henderson CA, Sun LW, Todd RD. Prenatal smoking exposure and dopaminergic genotypes interact to cause a severe ADHD subtype. Biol Psychiatry 2007;61(12):1320-1328 (Pubitemid 46855768)
43. Obel C, Linnet KM, Henriksen TB, et al. Smoking during pregnancy and hyperactivity-inattention in the offspring - comparing results from three Nordic cohorts. Int J Epidemiol 2009;38(3):698-705
44. Swanson JM, Kinsbourne M, Nigg J, et al. Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychol Rev 2007;17(1):39-59 (Pubitemid 46355008)
45. Cole JA, Modell JG, Haight BR, Cosmatos IS, Stoler JM, Walker AM. Bupropion in pregnancy and the prevalence of congenital malformations. Pharmacoepidemiol Drug Saf 2007;16(5):474-484 (Pubitemid 46824268)
46. Källén B, Otterblad Olausson P. Antidepressant drugs during pregnancy and infant congenital heart defect. Reprod Toxicol 2006;21(3):221-222 (Pubitemid 43294548)
47. Bellantuono C, Migliarese G, Gentile S. Serotonin reuptake inhibitors in pregnancy and the risk of major malformations: a systematic review. Hum Psychopharmacol 2007;22(3): 121-128 (Pubitemid 46730580)
48. Gentile S, Bellantuono C. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine. J Clin Psychiatry 2009;70(3):414-422
49. Chambers CD, Hernandez-Diaz S, Van Marter LJ, et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 2006;354(6):579-587 (Pubitemid 43209105)
50. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996;335(14):1010-1015 (Pubitemid 26338730)
51. Moses-Kolko EL, Bogen D, Perel J, et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 2005;293(19):2372-2383 (Pubitemid 40676760)
52. Koren G, Boucher N. Adverse effects in neonates exposed to SSRIs and SNRI in late gestation - Motherisk Update 2008. Can J Clin Pharmacol 2009;16(1):e66-e67
53. Toh S, Mitchell AA, Louik C, Werler MM, Chambers CD, Hernández- Díaz S. Selective serotonin reuptake inhibitor use and risk of gestational hypertension. Am J Psychiatry 2009; 166(3):320-328
54. Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C. Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study. Br J Psychiatry 2008;192(5):338-343 (Pubitemid 351692377)
55. Tan KS, Thomson NC. Asthma in pregnancy. Am J Med 2000;109(9):727-733
56. Bakhireva LN, Schatz M, Chambers CD. Effect of maternal asthma and gestational asthma therapy on fetal growth. J Asthma 2007;44(2):71-76 (Pubitemid 46439691)
57. Holmes LB, Harvey EA, Coull BA, et al. The teratogenicity of anticonvulsant drugs. N Engl J Med 2001;344(15):1132-1138
58. Adab N, Tudur SC, Vinten J, Williamson P, Winterbottom J. Common antiepileptic drugs in pregnancy in women with epilepsy. Cochrane Database Syst Rev 2004; (3):CD004848
59. Meador KJ, Penovich P, Baker GA, et al. Antiepileptic drug use in women of childbearing age. Epilepsy Behav 2009; May 26 (Epub ahead of print)
60. Meador KJ, Baker GA, Browning N, et al; NEAD Study Group. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 2009;360(16): 1597-1605
61. U.S. Preventive Services Task Force. Folic acid for the prevention of neural tube defects: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009;150(9):626-631
62. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 2001; 285(23):2981-2986
63. Abramsky L, Dolk H; EUROCAT Folic Acid Working Group. Should Europe fortify a staple food with folic acid? Lancet 2007;369(9562):641-642
64. Busby A, Abramsky L, Dolk H, et al. Preventing neural tube defects in Europe: a missed opportunity. Reprod Toxicol 2005;20(3):393-402 (Pubitemid 40943559)
65. Charles DH, Ness AR, Campbell D, Smith GD, Whitley E, Hall MH. Folic acid supplements in pregnancy and birth outcome: re-analysis of a large randomised controlled trial and update of Cochrane review. Paediatr Perinat Epidemiol 2005;19(2):112-124 (Pubitemid 40477232)
66. Bukowski R, Malone FD, Porter FT, et al. Preconceptional folate supplementation and the risk of spontaneous preterm birth: a cohort study. PLoS Med 2009;6(5):e1000061
67. Edison RJ, Berg K, Remaley A, et al. Adverse birth outcome among mothers with low serum cholesterol. Pediatrics 2007;120(4):723-733 (Pubitemid 47549559)
68. Steffen KM, Cooper ME, Shi M, et al. Maternal and fetal variation in genes of cholesterol metabolism is associated with preterm delivery. J Perinatol 2007;27(11):672-680 (Pubitemid 350020346)
69. Ehn NL, Cooper ME, Orr K, et al. Evaluation of fetal and maternal genetic variation in the progesterone receptor gene for contributions to preterm birth. Pediatr Res 2007;62(5): 630-635 (Pubitemid 351339003)
70. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 2008;359(1):61-73 (Pubitemid 351931097)
71. Larsen WJ, Sherman LS, Potter SS, Scott WS. Human Embryology. Philadelphia, PA: Churchill Livingstone; 2001
72. Lee JH, Hart SRL, Skalnik DG. Histone deacetylase activity is required for embryonic stem cell differentiation. Genesis 2004;38(1):32-38
73. Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 2007;447(7143):425-432 (Pubitemid 46816749)
74. Rasmussen TP. Embryonic stem cell differentiation: a chromatin perspective. Reprod Biol Endocrinol 2003;1:100
75. Santos F, Dean W. Epigenetic reprogramming during early development in mammals. Reproduction 2004;127(6):643-651 (Pubitemid 38878420)
76. Mackay J, Eriksen M. The Tobacco Atlas. Brighton, United Kingdom: World Health Organization; 2002
77. Waterland RA, Jirtle RL. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 2003;23(15):5293-5300
78. Dolinoy DC, Weidman JR, Waterland RA, Jirtle RL. Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ Health Perspect 2006;114(4):567-572
79. Meaney MJ, Szyf M. Environmental programming of stress responses through DNA methylation: life at the interface between a dynamic environment and a fixed genome. Dialogues Clin Neurosci 2005;7(2):103-123 (Pubitemid 40961531)
80. Ravelli GP, Stein ZA, Susser MW. Obesity in young men after famine exposure in utero and early infancy. N Engl J Med 1976;295(7):349-353
81. Gluckman PD, Hanson MA. Living with the past: evolution, development, and patterns of disease. Science 2004;305(5691): 1733-1736
82. McGowan PO, Sasaki A, D'Alessio AC, et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 2009;12(3): 342-348
83. McGowan PO, Sasaki A, Huang TC, et al. Promoter-wide hypermethylation of the ribosomal RNA gene promoter in the suicide brain. PLoS One 2008;3(5):e2085 (Pubitemid 352025112)
84. McMinn J, Wei M, Schupf N, et al. Unbalanced placental expression of imprinted genes in human intrauterine growth restriction. Placenta 2006;27(6-7):540-549
85. Tycko B. Imprinted genes in placental growth and obstetric disorders. Cytogenet Genome Res 2006;113(1-4):271-278
86. Haig D. Genetic conflicts in human pregnancy. Q Rev Biol 1993;68(4):495-532
87. Swanson JD, Wadhwa PM. Developmental origins of child mental health disorders. J Child Psychol Psychiatry 2008; 49(10):1009-1019